Visikol, a drug discovery and bio-imaging service provide, has relocated its entire operations to Whitehouse Station, its CEO Michael Johnson announced Monday.
The new facility, located at the Salem One Technology Complex, will have offices, laboratory and manufacturing spaces. It will quadruple the company’s physical footprint, Johnson said, and will be a major factor in its growth and expansion plans.
(READ MORE from ROI-NJ about Visikol.)
“The decision to expand and relocate our entire operation was a simple one. market conditions have dictated rapid growth in all areas of our organization and we needed to quickly expand our physical space to meet operational capacity. We are excited to be in a much improved facility and we negotiated a lease agreement that substantially improved our per square foot cost and includes options for an additional 6,000 square feet of adjoining space so we are well positioned for future and immediate expansion,” Johnson said.
Financial terms of the move were not disclosed.
